NCT05029518View on ClinicalTrials.gov

3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

December 10, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

SMP-100

In each period, subjects will receive a single dose of SMP-100 on Day 1 (Period 1), Day 4 (Period 2), and Day 7 (Period 3), under fasting or fed conditions, followed by 48 hours of PK and safety assessments.

Trial Locations (1)

SA 5000

CMAX Clinical Research Pty Ltd, Adelaide

All Listed Sponsors
lead

Chengdu SciMount Pharmatech Co., Ltd.

INDUSTRY

NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability | Biotech Hunter | Biotech Hunter